Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo V Hartung

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Science (New York, N.Y.)|July 30, 2021
No shortcuts to SARS-CoV-2 antiviralsAled Edwards, Ingo V Hartung
Angewandte Chemie (International Ed. in English)|April 6, 2004
8-Oxabicyclo[3.2.1]oct-6-en-3-ones: application to the asymmetric synthesis of polyoxygenated building blocksIngo V Hartung, H Martin R Hoffmann
Nature Reviews. Chemistry|April 28, 2023
Rules were made to be brokenIngo V Hartung, Bayard R Huck, Alejandro Crespo
Nature Reviews. Chemistry|October 25, 2023
The experiment is the limitChristina E M Schindler, Daniel Kuhn, Ingo V Hartung
RSC Medicinal Chemistry|June 5, 2025
Introduction to the themed collection on 'Induced-Proximity Pharmacology'Ingo V Hartung, Lindsey I James, Lyn H Jones
Angewandte Chemie (International Ed. in English)|June 24, 2003
The total syntheses of phorboxazoles--new classics in natural product synthesisLars Ole Haustedt, Ingo V Hartung, H M R Hoffmann
Organic Letters|September 14, 2002
Toward the total synthesis of disorazole A(1) and C(1): asymmetric synthesis of a masked southern segmentIngo V Hartung, Barbara Niess, Lars Ole Haustedt, et al.
Journal of the American Chemical Society|August 11, 2005
Stereochemical assignment of intermediates in the rifamycin biosynthetic pathway by precursor-directed biosynthesisIngo V Hartung, Mathew A Rude, Nathan A Schnarr, et al.
Cancer Discovery|September 15, 2023
Which Small Molecule? Selecting Chemical Probes for Use in Cancer Research and Target ValidationMary M Mader, Joachim Rudolph, Ingo V Hartung, et al.
Journal of Medicinal Chemistry|July 5, 2023
Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader ProbesIngo V Hartung, Joachim Rudolph, Mary M Mader, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Science (New York, N.Y.)|July 30, 2021
No shortcuts to SARS-CoV-2 antiviralsAled Edwards, Ingo V Hartung
Angewandte Chemie (International Ed. in English)|April 6, 2004
8-Oxabicyclo[3.2.1]oct-6-en-3-ones: application to the asymmetric synthesis of polyoxygenated building blocksIngo V Hartung, H Martin R Hoffmann
Nature Reviews. Chemistry|April 28, 2023
Rules were made to be brokenIngo V Hartung, Bayard R Huck, Alejandro Crespo
Nature Reviews. Chemistry|October 25, 2023
The experiment is the limitChristina E M Schindler, Daniel Kuhn, Ingo V Hartung
RSC Medicinal Chemistry|June 5, 2025
Introduction to the themed collection on 'Induced-Proximity Pharmacology'Ingo V Hartung, Lindsey I James, Lyn H Jones
Angewandte Chemie (International Ed. in English)|June 24, 2003
The total syntheses of phorboxazoles--new classics in natural product synthesisLars Ole Haustedt, Ingo V Hartung, H M R Hoffmann
Organic Letters|September 14, 2002
Toward the total synthesis of disorazole A(1) and C(1): asymmetric synthesis of a masked southern segmentIngo V Hartung, Barbara Niess, Lars Ole Haustedt, et al.
Journal of the American Chemical Society|August 11, 2005
Stereochemical assignment of intermediates in the rifamycin biosynthetic pathway by precursor-directed biosynthesisIngo V Hartung, Mathew A Rude, Nathan A Schnarr, et al.
Cancer Discovery|September 15, 2023
Which Small Molecule? Selecting Chemical Probes for Use in Cancer Research and Target ValidationMary M Mader, Joachim Rudolph, Ingo V Hartung, et al.
Journal of Medicinal Chemistry|July 5, 2023
Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader ProbesIngo V Hartung, Joachim Rudolph, Mary M Mader, et al.
Pageof 4